VeriMom¿Es peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
Related ingredients
Frequently asked questions
- ¿Es peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- ¿Es peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) seguro durante la lactancia?
- No data identified showing reproductive or lactation toxicity or transfer in breast milk for this ingredient. Mechanistic or animal evidence of transfer into milk was not found; expected systemic exposure from topical cosmetic use is low but measurable, so marginal potential for maternal systemic exposure exists. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- ¿Es peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) seguro para la piel del bebé?
- No infant‑specific toxicity or developmental data were identified. Because the ingredient is a PEGylated benzotriazole UV‑absorber (moderate molecular size) and topical absorption in infants is typically higher than in adults, exposure score is increased by +1 for baby skin; however no evidence was found indicating intrinsic reproductive/developmental hazard. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed, EWG.
- ¿Cómo puntúa VeriMom a peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate)?
- VeriMom puntúa peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) en el embarazo?
- Consulta nuestra lista de alternativas seguras a peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.